Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: January 2021
-
By Kevin E. Noonan — One of the most notable movie taglines, "Just when you thought it was safe to go back in the water," was used to market the sequel to the original summer blockbuster movie, Jaws. It is perhaps impossible to not think of that message upon learning that the Patent Trial and…
-
By Donald Zuhn –- After reflecting upon the events of the past twelve months, Patent Docs presents its 14th annual list of top patent stories. For 2020, we identified eight stories that were covered on Patent Docs last year that we believe had (or are likely to have) a significant impact on patent practitioners and…
-
By Kevin E. Noonan — Motion practice continues in Interference No. 106,115 between Senior Party The Broad Institute, Harvard University, and the Massachusetts Institute of Technology (collectively, "Broad") and Junior Party the University of California/Berkeley, the University of Vienna, and Emmanuelle Charpentier (collectively, "CVC"), with CVC filing on January 6th its Reply to Broad's opposition…
-
January 13, 2021 – "Second Medical Use Patents — Understanding Infringement and Enforcement" (Gowling WLG) – 9:00 to 10:00 am EST January 14, 2021 – "Priority Entitlement in Europe — Current Best Practice" (J A Kemp) – 2:30 to 3:30 pm GMT January 26, 2021 – "Second Medical Use Patents — Verifying Validity" (Gowling WLG)…
-
J A Kemp will be offering a webinar entitled "Priority Entitlement in Europe — Current Best Practice" on January 14, 2021 from 2:30 to 3:30 pm GMT (Greenwich Mean Time). Marc Wilkinson and Chris Milton of J A Kemp will provide a concise review of European case law and practice with respect to a patentee's…
-
Gowling WLG will be offering two webinars on second medical use patents from 9:00 to 10:00 am EST on January 13, 2021 and from 9:00 to 10:00 am EST on January 26, 2021. The first webinar, entitled "Understanding Infringement and Enforcement," will outline the key opportunities and obstacles surrounding second medical use patent protection, focusing…
-
By Kevin E. Noonan — Indefiniteness under U.S. patent law is a failure to satisfy the statutory requirements of 35 U.S.C. § 112(b), which reads: "The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention" (emphasis…
-
By Kevin E. Noonan — Cancer, the "Emperor of All Maladies" as it has been termed, has been studied for millennia. President Nixon's "War on Cancer" resulted in slow but steady progress, aided by the biotechnology revolution, the development of monoclonal antibodies (see Herceptin®) and more recent developments in immunological interventions like CAR-T cells (see…
-
By Donald Zuhn — Last month, Intellectual Property Owners Association (IPO) President Daniel J. Staudt sent a letter on behalf of the IPO to President-Elect Joe Biden and Vice President-Elect Kamala Harris "to recommend that intellectual property (IP) law and policy be priorities in your administration." The letter states that: The IP system is fundamental…
-
By Donald Zuhn — In an e-mail News Brief distributed last week, the U.S. Patent and Trademark Office reported on the participation to date in its COVID-19 Prioritized Examination Pilot Program. The pilot program, which was implemented last May, allows applicants that qualify for small or micro entity status to request prioritized examination without paying…
Patent Docs 